medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 2

<< Back Next >>

salud publica mex 2020; 62 (2)

Predictors of kidney function in a cohort of Mexican adults

Torrescano-de Labra EL, Cupul-Uicab LA, Ramírez-Palacios P, Salmerón J, Muñoz-Aguirre CP, Salazar-Martínez E

Language: Spanish
References: 40
Page: 156-165
PDF size: 292.80 Kb.


ABSTRACT

Objectives. Our aim was to examine prospectively predictors of subclinical renal alterations among adults without chronic kidney disease. Materials and methods. We analyzed data from a cohort of Mexican adults (n=757). Kidney function (2010) was assessed with the estimated glomerular filtration rate (eGFR-Cr), serum creatinine and uric acid. Predictors of each kidney function marker (2004) were identified with linear and logistic regression models. Results. 33% had an eGFR-Cr ‹90 ml/min/1.73 m2. eGFRCr was lower among men, those ›40 years old and users of antihypertensive medication; and higher among those with a high protein intake. Serum creatinine predictors were similar to those observed for eGFR-Cr. Uric acid decreased in men, among those with obesity, hypertension and high cholesterol. Conclusion. Conventional kidney function biomarkers are useful to identify subclinical alterations. Some predictors of kidney function are potentially modifiable, therefore susceptible for intervention among high-risk groups.


REFERENCES

  1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. https://doi. org/10.1016/s0140-6736(14)61682-2

  2. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, Levin A. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158-69. https://doi.org/10.1016/ S0140-6736(13)60439-0

  3. Global Burden of Disease Collaborative Network. GBD Results Tool. Global Burden of Disease Study 2016 2017. Washington: Institute for Health Metrics and Evaluation [citado febrero, 2019]. Disponible en: http:// ghdx.healthdata.org/gbd-results-tool

  4. Méndez-Durán A, Pérez-Aguilar G, Ayala-Ayala F, Ruiz-Rosas RA, González-Izquierdo J, Dávila-Torres J. Panorama epidemiológico de la insuficiencia renal crónica en el segundo nivel de atención del Instituto Mexicano del Seguro Social. Dial Traspl. 2014;35(4):148-56. https://doi. org/10.1016/j.dialis.2014.08.001

  5. Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1-150. https://doi. org/10.1038/kisup.2012.73

  6. McMahon GM, Waikar SS. Biomarkers in nephrology: Core Curriculum 2013. Am J Kidney Dis. 2013;62(1):165-78. https://doi.org/10.1053/j. ajkd.2012.12.022

  7. Levey AS, Inker LA. GFR as the “Gold Standard”: Estimated, measured, and true. Am J Kidney Dis. 2016;67(1):9-12. https://doi.org/10.1053/j. ajkd.2015.09.014

  8. Jhee JH, Hwang SD, Song JH, Lee SW. Upper normal serum creatinine concentrations as a predictor for chronic kidney disease: Analysis of 14 Years’ Korean Genome and Epidemiology Study (KoGES). J Clin Med. 2018;7(11):1-17. https://doi.org/10.3390/jcm7110463

  9. Tangri N, Inker LA, Tighiouart H, Sorensen E, Menon V, Beck G, et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol. 2012;23(2):351-59. https://doi. org/10.1681/ASN.2011070663

  10. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407-13. https://doi.org/10.1681/ ASN.2008010080

  11. Zhu P, Liu Y, Han L, Xu G, Ran JM. Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a metaanalysis of 15 cohort studies. PLoS One. 2014;9(6):e100801. https://doi. org/10.1371/journal.pone.0100801

  12. Méndez-Durán A, González-Cisneros RM, Mendoza-Galicia K. Identificación de enfermedad renal en sujetos aparentemente sanos, familiares de pacientes que acuden a hemodiálisis. Rev Esp Med Quir. 2012;17(1):29-33. https://www.redalyc.org/articulo.oa?id=47323260007

  13. Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386-2402. https://doi. org/10.1016/S0140-6736(16)31773-1

  14. Barquera S, Campos-Nonato I, Hernández-Barrera L, Pedroza A, Rivera-Dommarco JA. Prevalencia de obesidad en adultos mexicanos, ENSANUT 2012. Salud Publica Mex. 2013;55(supl 2):S151-60. https://doi. org/10.21149/spm.v55s2.5111

  15. Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60(3):224-32. https://doi.org/10.21149/8566

  16. Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S. Hipertensión arterial en adultos mexicanos: prevalencia, diagnóstico y tipo de tratamiento. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233-43. https://doi.org/10.21149/8813

  17. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol. 2011;301(5):F919-31. https://doi.org/10.1152/ajprenal.00068.2011

  18. Denova-Gutiérrez E, Flores YN, Gallegos-Carrillo K, Ramírez-Palacios P, Rivera-Paredez B, Muñoz-Aguirre P, et al. Health workers cohort study: methods and study design. Salud Publica Mex. 2016;58(6):708-16. https:// doi.org/10.21149/spm.v58i6.8299

  19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. https://doi.org/10.7326/0003-4819-150-9- 200905050-00006

  20. Saldana TM, Basso O, Darden R, Sandler DP. Carbonated beverages and chronic kidney disease. Epidemiology. 2007;18(4):501-6. https://doi. org/10.1097/EDE.0b013e3180646338

  21. World Health Organization. Guideline: Sodium intake for adults and children. Ginebra: WHO, 2012 [citado mayo 22, 2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/77985/9789241504836_ eng.pdf;jsessionid=E8FD360BD5E84E86EA60CAD760AE261F?sequen ce=1

  22. Serralda-Zúñiga AE, Meléndez-Mier G, Pasquetti-Ceccatelli A. Requerimientos y recomendaciones proteicas, referencias internacionales y mexicanas. Rev Endocrinol Nutr. 2003;11(2):73-9 [citado mayo 22, 2019]. Disponible en: http://imbiomed.mx/1/1/articulos. php?method=showDetail&id_articulo=16962&id_seccion=350&id_ ejemplar=1777&id_revista=23

  23. World Health Organization. A global brief on Hypertension. Silent killer, global public health crisis. Ginebra: WHO, 2013 [citado mayo 22, 2019]. Disponible en: http://apps.who.int/iris/bitstream/10665/79059/1/ WHO_DCO_WHD_2013.2_eng.pdf?ua=1

  24. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(suppl 1):S11-24. https://doi.org/10.2337/ dc17-S005

  25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. https://doi.org/10.1001/ jama.285.19.2486

  26. Lu JL, Molnar MZ, Naseer A, Mikkelsen MK, Kalantar-Zadeh K, Kovesdy CP. Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol. 2015;3(9):704-14. https://doi. org/10.1016/S2213-8587(15)00128-X

  27. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health. 2008;8:117. https://doi.org/10.1186/1471-2458-8-117

  28. Amato D, Alvarez-Aguilar C, Castañeda-Limones R, Rodriguez E, Avila-Diaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005(97):S11-17. https://doi. org/10.1111/j.1523-1755.2005.09702.x

  29. Salvador-González B, Rodríguez-Pascual M, Ruipérez-Guijarro L, Ferré-González A, Cunillera-Puertolas O, Rodríguez-Latre LM. Enfermedad renal crónica en atención primaria: prevalencia y factores de riesgo asociados. Aten Primaria. 2015;47(4):236-45. https://doi.org/10.1016/j. aprim.2014.06.003

  30. Arreola-Guerra JM, Rincón-Pedrero R, Cruz-Rivera C, Belmont-Pérez T, Correa-Rotter R, Niño-Cruz JA. Performance of MDRD-IDMS and CKD-EPI equations in Mexican individuals with normal renal function. Nefrologia. 2014;34(5):591-98 [citado mayo 22, 2019]. Disponible en: http:// scielo.isciii.es/scielo.php?pid=S0211-69952014000500007&script=sci_ arttext&tlng=en

  31. Secretaría de Salud México. Prevención, diagnóstico, tratamiento y referencia oportuna de hiperuricemia y gota. México: Secretaría de Salud, 2009 [citado mayo 22, 2019]. Disponible en: http://www.cenetec.salud.gob. mx/descargas/gpc/CatalogoMaestro/216_SSA_09_Hiperuricemia_Gota/ SSA-216-09_GOTAEVR.pdf

  32. Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y, Olchovsky D. Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol. 2013;111(8):1146-51. https://doi.org/10.1016/j. amjcard.2012.12.034

  33. Odden MC, Amadu AR, Smit E, Lo L, Peralta CA. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002. Am J Kidney Dis. 2014;64(4):550-7. https://doi.org/10.1053/j. ajkd.2014.04.024

  34. Salvador-González B, Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Güell-Miró R, Rodríguez-Latre LM, et al. Estimated glomerular filtration rate, cardiovascular events and mortality across age groups among individuals older than 60 years in Southern Europe. Rev Esp Cardiol (Engl Ed). 2018;71(6):450-57. https://doi.org/10.1016/j.rec.2017.09.010

  35. Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJ, et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int. 2011;80(3):282-87. https://doi.org/10.1038/ki.2011.79

  36. Halbesma N, Jansen DF, Stolk RP, De Jong PE, Gansevoort RT, PREVEND Study group. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. Nephrol Dial Transplant. 2010;25(6):1846-53. https://doi.org/10.1093/ndt/gfp729

  37. Okada R, Wakai K, Naito M, Morita E, Kawai S, Yin G, et al. Renal hyperfiltration in prediabetes confirmed by fasting plasma glucose and hemoglobin A1c. Ren Fail. 2012;34(9):1084-90. https://doi.org/10.3109/088 6022X.2012.717516

  38. Morales-Buenrostro LE, Ramos-Gordillo JM. Etapas tempranas de la ERC: detección y manejo. En: Tamayo y Orozco JA, Lastiri Quirós HS, eds. La enfermedad renal crónica en México. Hacia una política nacional para enfrentarla. México: Conacyt, ANMM, 2016:27-37 [citado mayo 22, 2019]. Disponible en: https://www.anmm.org.mx/publicaciones/ultimas_publicaciones/ ENF-RENAL.pdf

  39. So R, Song S, Lee JE, Yoon HJ. The Association between renal hyperfiltration and the sources of habitual protein intake and dietary acid load in a general population with preserved renal function: The KoGES Study. PLoS One. 2016;11(11):1-12. https://doi.org/10.1371/journal. pone.0166495

  40. Juraschek SP, Appel LJ, Anderson CA, Miller ER 3rd. Effect of a highprotein diet on kidney function in healthy adults: results from the Omni- Heart trial. Am J Kidney Dis. 2013;61(4):547-54. https://doi.org/10.1053/j. ajkd.2012.10.017




2020     |     www.medigraphic.com